|

silevertinib in combination with temozolomide Clinical Trials

1 actively recruiting trial across 1 location

Also known as: BDTX-1535, TMZ, Temodar

Pipeline

Phase 2: 1

Top Sponsors

  • Black Diamond Therapeutics, Inc.1

Indications

  • Newly Diagnosed Glioblastoma1
  • Central Nervous System Diseases1
  • Glioblastoma Multiforme (GBM)1
  • Glioblastoma (GBM)1
  • GBM1

Springdale, Arkansas1 trial

Study of Silevertinib With Temozolomide for the Treatment of Newly Diagnosed GBM With Unmethylated MGMT and EGFRvIII

Highlands Oncology Group

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.